dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Janssen, Harry L A |
dc.contributor.author | Hou, Jinlin |
dc.contributor.author | Asselah, Tarik |
dc.contributor.author | Chan, Henry Lik Yuen |
dc.contributor.author | Zoulim, Fabien |
dc.contributor.author | Tanaka, Yasuhito |
dc.contributor.author | Buti Ferret, Maria |
dc.date.accessioned | 2023-06-14T09:41:00Z |
dc.date.available | 2023-06-14T09:41:00Z |
dc.date.issued | 2023-07 |
dc.identifier.citation | Janssen HLA, Hou J, Asselah T, Chan HLY, Zoulim F, Tanaka Y, et al. Randomised phase 2 study (JADE) of the HBV capsid assembly modulator JNJ-56136379 with or without a nucleos(t)ide analogue in patients with chronic hepatitis B infection. Gut. 2023 Jul;72(7):1385–98. |
dc.identifier.issn | 1468-3288 |
dc.identifier.uri | https://hdl.handle.net/11351/9744 |
dc.description | Hepatitis crònica; Hepatitis B |
dc.description.sponsorship | This study was sponsored by Janssen (award/grant number: not applicable). |
dc.language.iso | eng |
dc.publisher | BMJ |
dc.relation.ispartofseries | Gut;72(7) |
dc.rights | Attribution-NonCommercial 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc/4.0/ |
dc.source | Scientia |
dc.subject | Hepatitis B - Tractament |
dc.subject | Medicaments antivírics - Ús terapèutic |
dc.subject.mesh | Hepatitis B, Chronic |
dc.subject.mesh | /drug therapy |
dc.subject.mesh | Antiviral Agents |
dc.subject.mesh | /therapeutic use |
dc.title | Randomised phase 2 study (JADE) of the HBV capsid assembly modulator JNJ-56136379 with or without a nucleos(t)ide analogue in patients with chronic hepatitis B infection |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1136/gutjnl-2022-328041 |
dc.subject.decs | hepatitis B crónica |
dc.subject.decs | /farmacoterapia |
dc.subject.decs | antivíricos |
dc.subject.decs | /uso terapéutico |
dc.relation.publishversion | http://dx.doi.org/10.1136/gutjnl-2022-328041 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Janssen HLA] Toronto General Hospital, Toronto, Ontario, Canada. Erasmus Medical Center, Rotterdam, Zuid-Holland, The Netherlands. [Hou J] Nanfang Hospital, Southern Medical University, Guangzhou, China. [Asselah T] Université de Paris Cité, INSERM UMR1149, Hôpital Beaujon AP-HP, Clichy, France. [Chan HLY] The Chinese University of Hong Kong, Hong Kong SAR, China. [Zoulim F] Hospices Civils de Lyon and Lyon University & INSERM U1052-Cancer Research Institute of Lyon, Lyon, France. [Tanaka Y] Department of Gastroenterology and Hepatology, Kumamoto University, Kumamoto, Japan. [Buti M] Vall d’Hebron Hospital Universitari, Barcelona, Spain. CIBERHED del Instituto Carlos III, Barcelona, Spain |
dc.identifier.pmid | 36697207 |
dc.identifier.wos | 000921642100001 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |